Ajanta Pharma Announcements
Ajanta Pharma Limited has informed the Exchange that Record date for the purpose of Dividend is 10-Nov-2025
24 Oct, 2025 | 10:21am • Source:
Board in its meeting scheduled to be held on 3rd November 2025 will consider fixation of record date for the purpose of 1st Interim Dividend...
24 Oct, 2025 | 10:02am • Source: BSE
Board in its meeting scheduled to be held on 3rd November 2025 will consider declaration of 1st Interim Dividend.
24 Oct, 2025 | 09:56am • Source: BSE
Ajanta Pharma Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 03/11/2025 ,inter alia, to consider and...
24 Oct, 2025 | 09:49am • Source: BSE
Pls find enclosed Investor Call Intimation
08 Oct, 2025 | 04:47pm • Source: BSE
Ajanta Pharma Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 03/11/2025 ,inter alia, to consider and...
08 Oct, 2025 | 12:41pm • Source: BSE
Please find enclosed herewith Sustainability Report for FY 2025, prepared in accordance with the Global Reporting Initiative (GRI) Standards.
08 Oct, 2025 | 12:12pm • Source: BSE
Pls find enclosed herewith Certificate under Regulation 74(5) of SEBI (DP) Regulations 2018.
08 Oct, 2025 | 11:53am • Source: BSE
The Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on October 03, 2025 for...
03 Oct, 2025 | 05:17pm • Source: BSE
The Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on October 03, 2025 for...
03 Oct, 2025 | 03:12pm • Source: BSE
The Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on September 25, 2025 for...
26 Sep, 2025 | 10:39am • Source: BSE
PFA Intimation w.r.t Closure of Trading Window
25 Sep, 2025 | 02:01pm • Source: BSE
The Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on September 16, 2025 for...
16 Sep, 2025 | 10:41am • Source: BSE
The Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on September 10, 2025 for...
10 Sep, 2025 | 03:02pm • Source: BSE
Pls find enclosed Newspaper Advertisement
08 Sep, 2025 | 12:40pm • Source: BSE
Ajanta Pharma Limited has informed the Exchange about Participation in Investor Conference
02 Sep, 2025 | 09:58am • Source: NSE
Please find enclosed intimation w.r.t Participation in Investor Conference.
02 Sep, 2025 | 09:05am • Source: BSE
Pls find enclosed Intimation under Regulation 30 of SEBI LODR Regulations 2015.
20 Aug, 2025 | 09:33pm • Source: BSE
Pls find enclosed Written Transcript of Earnings Call held on 28th July 2025.
31 Jul, 2025 | 11:06am • Source: BSE
Ajanta Pharma Limited has informed the Exchange about Copy of Newspaper Publication
29 Jul, 2025 | 11:58am • Source: NSE